Cromos Pharma, where the patients are

AMRI

AMRI shutters New York research center, cuts 45 jobs

Friday, April 18, 2014 12:39 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, N.Y., site to other sites within AMRI and will cease operations in Syracuse by the end of June.

More... »

CRF Health eCOA webinar series

AMRI to acquire Cedarburg Pharmaceuticals

Monday, March 24, 2014 02:42 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization based in Albany, N.Y., will acquire all outstanding shares of Cedarburg Pharmaceuticals for $38.2 million in cash. The transaction, including $2.8 million of assumed liabilities, is valued at $41 million.

More... »


AMRI Hires Vijay Kumar Batra as Managing Director, AMRI India

Wednesday, January 15, 2014 07:52 AM

Albany Molecular Research, a global contract research and manufacturing organization, has appointed Vijay Kumar Batra to managing director, AMRI India, effective Jan. 2. Batra will report to Steve Hagen, Ph.D., senior vice president of manufacturing and pharmaceuticals.

More... »

AMRI announces lifting of FDA warning letter

Wednesday, November 13, 2013 09:27 AM

Albany, N.Y.-based Albany Molecular Research (AMRI) has received a close-out letter from the FDA lifting a 2010 warning letter related to its Burlington, Mass., aseptic fill-and-finish facility.

More... »

AMRI awarded contract from U.K. government

Monday, October 7, 2013 03:22 PM

U.K.-based CRO Albany Molecular Research, a wholly owned subsidiary of AMRI, has been awarded a seven-year contract for the development and manufacture of an active ingredient under clinical evaluation. The contract was awarded by the Defense Science and Technology Laboratory, acting on behalf of the U.K.'s Secretary of State for Defense, the Department of National Defense of Canada and Minister of Defense of the Kingdom of the Netherlands.

More... »

AMRI announces executive leadership changes

Tuesday, September 10, 2013 10:01 AM

CRO Albany Molecular Research has announced Thomas E. D'Ambra, Ph.D., will retire as president and chief executive officer, effective Dec. 31. D'Ambra will be named non-executive chairman of the board of directors on the same date.

More... »

AMRI names business development director

Monday, June 17, 2013 02:00 PM

AMRI named Susan Collins director of business development for North American Discovery Services, reporting to Christopher Conway, vice president of business development. Collins is responsible for leading a team promoting AMRI's global drug discovery services.

More... »

AMRI, Ono Pharma broaden Smartsourcing collaboration

Monday, April 29, 2013 11:21 AM

AMRI, a global contract research and manufacturing organization, has entered into a new five-year service agreement with Ono Pharmaceutical, a pharmaceutical company based in Osaka, Japan

More... »

AMRI, GE Healthcare extend long term supply relationship

Monday, December 10, 2012 01:16 PM

AMRI, a global contract research and manufacturing organization, has extended its commercial supply relationship with GE Healthcare for Aminobisamide Hydrochloride (ABA).

More... »

Drug discovery services market to reach $16.6B in 2015

Monday, December 10, 2012 10:09 AM

A new report by visiongain, an independent media company based in London, predicts that the world market for drug discovery outsourcing will reach $16.6 billion in 2015. That revenue forecast and others appear in “DrugDiscovery Outsourcing: World Market 2013-2023,” published in November 2012.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs